John Yee

Biography

Dr. Yee joined Intarcia in February 2016 as Vice President, Global Medical Affairs, Safety, and Operations. Dr. Yee has two decades of leadership experience at leading pharmaceutical, biotechnology, and health care companies, and at a major academic medical center. Prior to joining Intarcia, Dr. Yee served as VP, Head of Medical Affairs, US Diabetes, and VP, US Head Medical Officer at AstraZeneca, where he led medical affairs across all therapeutic areas, and led the medical launch of multiple cardiovascular and metabolic products including Bydureon®, Farxiga®, Xigduo™ XR, Myalept®, and Brilinta®. He launched the first-in-industry field-based medical team dedicated to serving physician assistants and nurse practitioners, and a multidisciplinary diabetes scientific advisory group, including specialists, primary care providers, patient advocates and health policy experts. Dr. Yee previously served in progressive leadership roles at Genzyme, including Global Medical Director; VP, US Medical Affairs; and VP, Global Medical Affairs for the company’s rare genetic disease business and VP, Global Head, Evidence-Based Medicine across all therapeutic areas. Earlier in his career, Dr. Yee helped lead two health care start-up companies, and was recognized by Fast Company magazine’s inaugural “Fast 50” list of “champions of innovation,” and by Boston Business Journal’s “40 Under 40” list of business leaders. Prior to joining industry, Dr. Yee served as a faculty member and attending physician at Harvard Medical School and Boston Children’s Hospital. He completed his residency training in pediatrics and fellowship training in immunology/rheumatology and health services research at Boston Children’s Hospital. Dr. Yee earned his undergraduate degree from Harvard College, and completed his medical degree at Harvard Medical School, in addition to a master’s degree in public health from the Harvard T.H. Chan School of Public Health. 

Research Interest

 His research interest in Business and Management